These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Changes of isoenzymes of serum N-acetyl-beta-D-glucosaminidase in relation to different types of diabetes. Mandić L; Filipović D Biochem Mol Biol Int; 1998 Jul; 45(3):545-54. PubMed ID: 9679655 [TBL] [Abstract][Full Text] [Related]
23. Beta-N-acetylhexosaminidase in the urine, kidney and serum of bromobenzene-intoxicated mice. Tassi C; Beccari T; Casini A; Orlacchio A Clin Chim Acta; 1992 Mar; 206(3):231-9. PubMed ID: 1535033 [TBL] [Abstract][Full Text] [Related]
24. [Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications]. Chistiakov DA; Turakulov RI; Girashko NM; Demurov LM; Rachiba IuM; Kondrat'ev IaIu; Milen'kaia TM; Shestakova MV; Dedov II; Nosikov VV Mol Biol (Mosk); 1997; 31(5):778-83. PubMed ID: 9454059 [No Abstract] [Full Text] [Related]
25. Proliferative retinopathy and nephropathy at presentation in young insulin dependent diabetics. O'Hare JA BMJ; 1990 Mar; 300(6724):579-80. PubMed ID: 2108753 [No Abstract] [Full Text] [Related]
26. Effect of smoking on activity of N-acetyl-beta-hexosaminidase in serum and urine of renal cancer patients. Borzym-Kluczyk M; Radziejewska I; Zaniewska A; Borzym-Lewszuk A; Szajda SD; Knaś M; Zwierz K; Darewicz B Clin Biochem; 2009 Oct; 42(15):1565-7. PubMed ID: 19615986 [TBL] [Abstract][Full Text] [Related]
28. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients. Agardh E; Gaur LK; Lernmark A; Agardh CD J Diabetes Complications; 2004; 18(1):32-6. PubMed ID: 15019597 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme gene polymorphism is associated with proliferative diabetic retinopathy: a meta-analysis. Zhou JB; Yang JK Acta Diabetol; 2010 Dec; 47 Suppl 1():187-93. PubMed ID: 19865794 [TBL] [Abstract][Full Text] [Related]
30. Metabolic factors in the development of retinopathy of juvenile-onset type I diabetes mellitus. Khosla PK; Sharma K; Tewari HK; Bajaj JS; Vaidya MC Indian J Ophthalmol; 1994 Mar; 42(1):23-5. PubMed ID: 7927626 [TBL] [Abstract][Full Text] [Related]
32. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Parving HH Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441 [TBL] [Abstract][Full Text] [Related]
33. Microalbuminuria and severity of diabetic retinopathy in type 1 diabetic patients: association and relationship with some risk factors. Crimi S; Cipolli D; Infantone E; Infantone L; Lunetta M Diabete Metab; 1995 Dec; 21(6):440-5. PubMed ID: 8593926 [TBL] [Abstract][Full Text] [Related]
34. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy. Davis TM; Moore JC; Turner RC Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410 [TBL] [Abstract][Full Text] [Related]
35. Platelet antioxidant enzymes in insulin-dependent diabetes mellitus. Seghieri G; Di Simplicio P; Anichini R; Alviggi L; De Bellis A; Bennardini F; Franconi F Clin Chim Acta; 2001 Jul; 309(1):19-23. PubMed ID: 11408002 [TBL] [Abstract][Full Text] [Related]
36. [Diabetic microangiopathy. Role of capillaroscopy]. Mouthon JM; Bosquet F; Grimaldi A; Wechsler B; Thervet F; Godeau P Presse Med; 1989 Oct; 18(33):1647-50. PubMed ID: 2530551 [TBL] [Abstract][Full Text] [Related]
37. Blood antioxidant parameters in patients with diabetic retinopathy. Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896 [TBL] [Abstract][Full Text] [Related]
38. Is the carbon monoxide transfer factor diminished in the presence of diabetic retinopathy in patients with insulin-dependent diabetes mellitus? Britton J Eur Respir J; 1988 May; 1(5):403-6. PubMed ID: 3169210 [TBL] [Abstract][Full Text] [Related]
39. Superoxide dismutase in the anterior chamber and the vitreous of diabetic patients. Kernell A; Lundh BL; Marklund SL; Skoog KO; Björkstén B Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3131-5. PubMed ID: 1399417 [TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy. Ben-Mahmud BM; Mann GE; Datti A; Orlacchio A; Kohner EM; Chibber R Diabetes; 2004 Nov; 53(11):2968-76. PubMed ID: 15504978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]